Aristotle University Of Thessaloniki (AUTH)
Λειτουργία του μετωπιαίου λοβού και γενετικοί πολυμορφισμοί στην νόσο του Parkinson
Abstract
dc:descriptionParkinson’s disease (PD) is a progressive neurodegenerative brain disorder of unknown etiology. Cognitive deficits particularly frontal lobe dysfunction are quite frequent in PD patients. However there are large inter-individual differences between patients concerning the type and severity of cognitive dysfunction. The relationship between specific clinical characteristics of the disease or response to treatment and a specific genotype have been explored, leading to controversial results. Taking into consideration that dopamine depletion is a pertinent characteristic of PD, we hypothesized that certain genes related to dopamine metabolism may be suitable candidates for investigation in relation to frontal lobe function in PD patients. Suitable gene candidates for these study are genes regulating catechol-O-methyl transferase (COMT) and monoaminoxidase B (MAO-B) activity. The study population consisted of 130 PD patients (77 men and 53 women) with a mean age of 60.58±9.51 years and 130 normal matched subjects (controls). The Val158Met COMT polymorphism and the A644G single nucleotide polymorphism within intron 13 of the MAO-B gene were assessed using a PCR-restriction fragmentation length polymorphism (PCR-RFLP) method. Furthermore PD patients’ cognitive function was assessed by means of a wide range of cognitive tests yielding information about general cognitive ability and specific aspects of frontal lobe function. These tests included: Mattis Dementia Rating Scale (DRS), Test of Non Verbal Intelligence (TONI-2), Wisconsin Card Sorting Test (WCST), Frontal Assessment Battery (FAB), Working Memory span, Word Fluency (WF) and Trail Making test, part A&B. Genetic analysis yielded the following results: A) The frequencies of the three COMT genotypes in PD patients were: High COMT activity (H/H)=45.7%; intermediate COMT activity (H/L)=37.2%; and low COMT activity (L/L)=17.05%. In normal controls (NC) the three genotype frequencies were: H/H= 31.7%; H/L=39.7; L/L=28.6%. The difference between the two groups was significant (p=0.030). B) The frequencies of MAO-B genotypes in PD patients were A/A=34.88 %; A/G =22.48%; G/G=42.64%. In normal controls the same genotype frequencies were: A/A=7.7 %; A/G =54.8%; G/G=37.5%. The difference between PD and NC was significant (p=0.000). Exploring the relationship of general cognitive ability as tested by the DRS and TONI-2 tests and the three COMT genotypes in PD patients, we observed a difference in a subscale of the DRS, namely the construction ability subscale (p=0.038). All other comparisons were not significant. In specific frontal lobe function tests there was a difference in the inhibitory control subscale of the FAB test and in total number correct of the WCST. All other comparisons were not significant. In the three MAO-B genotypes there was no difference in cognitive tests performance between groups. Finally, exploring the relationship of cognitive function and various combinations of summated groups of both genotypes we could not prove a relationship. In conclusion, our study showed a difference in COMT and MAO-B genotype frequencies between PD patients and NC. General cognitive ability and frontal lobe function showed only a subtle relationship to COMT and MAO-B genotypes suggesting that cognitive function in PD cannot be predicted by these genetic factors.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Κουρτέση, Γεωργία
- Kourtesi, Georgia
Subjects
dc:subject × 20- Νόσος Πάρκινσον
- Μετωπιαίος λοβός
- Εκτελεστική λειτουργία
- Γνωστικές διαταραχές
- Γενετικοί πολυμορφισμοί
- Μνήμη εργασίας
- Πολυμορφισμός κατεχολ-μεθυλ-τρανσφεράσης
- Πολυμορφισμός μονοαμινοξειδάσης-Β
- Parkinson's disease
- Frontal lobe
- Executive function
- Cognitive disorders
- Genetic polymorphisms
- Working memory
- Catechol-methyl-transferase (COMT) polymorphism
- Monoaminoxidase-B (MAO-B) polymorphism
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28524